{"sourcedb":"DevicePMAs@therightstef","sourceid":"P100022_S020","text":"Approval for the Zilver PTX Drug-Eluting Peripheral Stent is indicated for improving luminal diameter for the treatment of de novo or restenotic symptomatic lesions in native vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter from 4 mm to 7 mm and total lesion lengths up to 300 mm per patient.","project":"consensus_PMA_Age_Indications"}